Application of Critical Volume-Dose Constraints for Stereotactic Body Radiation Therapy in NRG Radiation Therapy Trials

Affiliations

• ¹ Department of Radiation Oncology, Hunter Holmes McGuire VA Medical Center, Richmond, Virginia; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; NRG Radiation Oncology Committee and/or NRG Medical Physics Subcommittee. Electronic address: timritte@med.umich.edu.
• ² Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; NRG Radiation Oncology Committee and/or NRG Medical Physics Subcommittee.
• ³ Department of Radiation Oncology, Henry Ford Health System, Detroit, Michigan; NRG Radiation Oncology Committee and/or NRG Medical Physics Subcommittee.
• ⁴ Department of Radiation Oncology, Duke University, Durham, North Carolina; NRG Radiation Oncology Committee and/or NRG Medical Physics Subcommittee.
• ⁵ Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas; NRG Radiation Oncology Committee and/or NRG Medical Physics Subcommittee.
• ⁶ Department of Radiation Oncology, The Ohio State University, Columbus, Ohio; NRG Radiation Oncology Committee and/or NRG Medical Physics Subcommittee.
• ⁷ Department of Radiation Oncology, Washington University, St. Louis, Missouri; NRG Radiation Oncology Committee and/or NRG Medical Physics Subcommittee.
• ⁸ Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania; NRG Radiation Oncology Committee and/or NRG Medical Physics Subcommittee.